{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:58Z","timestamp":1780426918268,"version":"3.54.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    This study explores the causal relationship between hematologic parameters and prostate cancer (PCa) risk, offering insights into potential biological pathways and clinical implications. We used genome-wide association studies to perform forward and reverse Mendelian randomization (MR) within a 2-sample framework. Additionally, multivariable MR was employed to assess the associations between multiple hematological markers and PCa. Several sensitivity analyses were conducted to ensure the robustness of the findings. Univariable MR analysis showed that genetically predicted mean corpuscular volume (OR: 0.942, 95% CI: 0.891\u20130.996,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.035) and mean corpuscular hemoglobin (OR: 0.934, 95% CI: 0.882\u20130.988,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.018) were associated with reduced PCa risk. Conversely, increases in eosinophil (OR: 1.081, 95% CI: 1.005\u20131.163,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.036) and basophil counts (OR: 1.235, 95% CI: 1.006\u20131.516,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.044) were linked to higher PCa risk. Multivariable MR highlighted a stronger association between basophil count and PCa (OR: 1.432, 95% CI: 1.028\u20131.996,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.034). Reverse MR indicated that PCa may increase neutrophil (OR: 1.012, 95% CI: 1.001\u20131.023,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.031) and red blood cell counts (OR: 1.008, 95% CI: 1.000\u20131.016,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.042). Our findings reveal causal associations between hematological parameters and PCa, improving understanding of the genetic links and potential interactions between these markers and PCa risk.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044775","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:00:47Z","timestamp":1759248047000},"page":"e44775","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hematological parameters as predictors of prostate cancer: A study based on multivariable and bidirectional Mendelian randomization"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2963-1557","authenticated-orcid":false,"given":"Yirui","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of TCM Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","first-page":"17","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches.","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology.","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part i: prostate cancer screening.","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/cvr\/cvab241","article-title":"Testosterone therapy and cardiovascular diseases.","volume":"118","author":"Cittadini","year":"2022","journal-title":"Cardiovasc Res"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1158\/1055-9965.EPI-19-1525","article-title":"Hematologic markers and prostate cancer risk: a prospective analysis in UK biobank.","volume":"29","author":"Watts","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s11255-021-02900-z","article-title":"Pre-treatment red blood cell distribution width as a predictor of clinically significant prostate cancer.","volume":"53","author":"Huang","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"22089","DOI":"10.1038\/srep22089","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.","volume":"6","author":"Gu","year":"2016","journal-title":"Sci Rep"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12885-015-1599-9","article-title":"Neutrophil count is associated with survival in localized prostate cancer.","volume":"15","author":"Bahig","year":"2015","journal-title":"BMC Cancer"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"271.e9","DOI":"10.1016\/j.urolonc.2022.03.016","article-title":"Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.","volume":"40","author":"Hadadi","year":"2022","journal-title":"Urol Oncol"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12874-022-01797-1","article-title":"Quality of observational studies of clinical interventions: a meta-epidemiological review.","volume":"22","author":"Grosman","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"618829","DOI":"10.3389\/fgene.2021.618829","article-title":"Mendelian randomization with refined instrumental variables from genetic score improves accuracy and reduces bias.","volume":"12","author":"Lin","year":"2021","journal-title":"Front Genet"},{"key":"R13-20260602","first-page":"a041302","article-title":"Mendelian randomization.","volume":"12","author":"Birney","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2023","journal-title":"Wellcome Open Res"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"471","DOI":"10.23736\/S2724-6051.19.03564-1","article-title":"Incidental prostate cancer after transurethral resection of the prostate: analysis of incidence and risk factors in 458 patients.","volume":"73","author":"Porcaro","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"1020655","DOI":"10.3389\/fendo.2022.1020655","article-title":"Preoperative red cell distribution width is associated with postoperative lymphovascular invasion in prostate cancer patients treated with radical prostatectomy: a retrospective study.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.7314\/APJCP.2014.15.18.7781","article-title":"Red cell distribution width as a predictor of prostate cancer progression.","volume":"15","author":"Albayrak","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s40001-023-01562-0","article-title":"The clinical association between coagulation indexes, platelet-related parameters, and bone metastasis of newly diagnosed prostate cancer.","volume":"28","author":"Yu","year":"2023","journal-title":"Eur J Med Res"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"845288","DOI":"10.3389\/fsurg.2022.845288","article-title":"Mean platelet volume enhances the diagnostic specificity of PSA for prostate cancer.","volume":"9","author":"Song","year":"2022","journal-title":"Front Surg"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy.","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"15141","DOI":"10.3390\/ijms242015141","article-title":"Erythroid cells as full participants in the tumor microenvironment.","volume":"24","author":"Shevchenko","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors.","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/all.12103","article-title":"Eosinophil-derived cytokines in health and disease: unraveling novel mechanisms of selective secretion.","volume":"68","author":"Melo","year":"2013","journal-title":"Allergy"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.08-RAI-0056","article-title":"Human basophils and cytokines\/chemokines.","volume":"58","author":"Yamaguchi","year":"2009","journal-title":"Allergol Int"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"110750","DOI":"10.1016\/j.isci.2024.110750","article-title":"Innate immune cells in tumor microenvironment: a new frontier in cancer immunotherapy.","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41385-022-00484-0","article-title":"TGF-\u03b2 production by eosinophils drives the expansion of peripherally induced neuropilin(-) ROR\u03b3t(+) regulatory T-cells during bacterial and allergen challenge.","volume":"15","author":"Fallegger","year":"2022","journal-title":"Mucosal Immunol"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13046-024-03129-1","article-title":"IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cells.","volume":"43","author":"Gambardella","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"issue":"Pt 4","key":"R30-20260602","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1042\/BST0350698","article-title":"Bone marrow stromal cells promote growth and survival of prostate cancer cells.","volume":"35","author":"Cross","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1038\/cddis.2011.141","article-title":"Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer.","volume":"3","author":"Cook","year":"2012","journal-title":"Cell Death Dis"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine.","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:01:27Z","timestamp":1780423287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":32,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044775","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2024-12-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}